Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO5093151 in Glaucoma and Ocular Hypertension
NCT01493271Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of RO5093151 in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Roche. Started Dec 2011; status: completed.
02
Drugs
RO5093151
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01493271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493271.